Chapter 3364-70 - Research Protection and Practices
- Section 3364-70-01 - Financial conflicts of interest
- Section 3364-70-02 - Research data and responsible conduct of scholarship and research
- Section 3364-70-03 - Research council
- Section 3364-70-04 - Patent Policy
- Section 3364-70-05 - Protection of human subjects in research
- Section 3364-70-06 - Use of biohazardous materials, recombinant and synthetic nucleic acids, stem cells, and toxins in research
- Section 3364-70-09 - Compensation for treatment of injuries to subjects in covered commercially sponsored clinical trials
- Section 3364-70-10 - Laboratory animal welfare, care and use
- Section 3364-70-12 - Material transfer policy
- Section 3364-70-13 - Disposition of start-up equity
- Section 3364-70-14 - Copyright policy
- Section 3364-70-15 - Commercialization policy
- Section 3364-70-16 - Research-related centers and institutes
- Section 3364-70-18 - Faculty and staff compensation and budgeting for sponsored programs
- Section 3364-70-21 - Policy on integrity in research and procedures for investigating allegations of research misconduct
- Section 3364-70-22 - Principal investigator's responsibilities on sponsored projects
- Section 3364-70-23 - Facilities and administrative "F&A" costs for sponsored research and programs
- Section 3364-70-26 - Audio/visual recording in university of Toledo ("UToledo") animal housing and use areas
- Section 3364-70-27 - The use of controlled substances and dangerous drugs in animal and in-vitro research
- Section 3364-70-28 - Internal auditing of clinical research policy
- Section 3364-70-29 - Dual use research of concern (DURC) - research involving select agents or toxins that provides knowledge but can also be misapplied